Clinical Trials · NCT05901467
Recall by Genotype: Neuropeptide Stimulation
- Phase
- Phase 1
- Recruitment status
- Terminated
- Sponsor
- Stephanie B. Seminara, MD
- Enrollment
- 16
- Start date
- Oct 2023
- Locations
- 1 site, United States
- Primary endpoint
- Endogenous LH Pulse Amplitude